Active Ingredient: Atazanavir
Atazanavir, co-administered with low dose ritonavir, is indicated for the treatment of HIV-1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products.
For this indication, competent medicine agencies globally authorize below treatments:
Oral
200 - 300 mg
From 200 To 300 mg once every day
The dose of atazanavir capsules for paediatric patients is based on body weight as shown in the following table and should not exceed the recommended adult dose. Atazanavir capsules must be taken with ritonavir and have to be taken with food.
Dose for paediatric patients (6 years to less than 18 years of age and weighing at least 15 kg) for atazanavir capsules with ritonavir:
| Body Weight (kg) | atazanavir once daily dose | ritonavir once daily dosea |
|---|---|---|
| 15 to less than 35 | 200 mg | 100 mg |
| at least 35 | 300 mg | 100 mg |
a Ritonavir capsules, tablets or oral solution.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
